Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): Results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005

British Journal of Haematology

Volumn 154, Issue 5, 2011, Pages 600-611

  Rives, Susana ^a,b   Estella, Jesús ^a   Gómez, Pedro ^c   López Duarte, Mónica ^d   de Miguel, Purificación García ^e   Verdeguer, Amparo ^f   Moreno, Maria José ^g   Vivanco, José Luis ^h   Couselo, José Miguel ⁱ   Fernández Delgado, Rafael ^j   Maldonado, Marisol ^k   Tasso, María ^l   López Ibor, Blanca ^m   Lendínez, Francisco ⁿ   López Almaraz, Ricardo ^o   Uriz, Javier ^p   Melo, Montserrat ^q   Fernández Teijeiro, Ana ^r   Rodríguez, Isidoro ^s   Badell, Isabel ^t  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL UNIVERSITARIO LA FE   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^h HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k HOSPITAL RAMÓN Y CAJAL   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^m Montepríncipe University Hospital   (Spain)

ⁿ HOSPITAL TORRECÁRDENAS   (Spain)

^o HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^p HOSPITAL DONOSTIA   (Spain)

^q HOSPITAL DE SABADELL   (Spain)

^r HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^s Hospital María Teresa Herrera Juan Canalejo   (Spain)

^t UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

more..

Author keywords

BCR ABL1; Children; Imatinib; Philadelphia chromosome acute lymphoblastic leukaemia; Stem cell transplantation

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; HYDROCORTISONE; IMATINIB; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL INFECTION; BLEEDING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; EVENT FREE SURVIVAL; FEMALE; FLUID RETENTION; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HERPES SIMPLEX; HLA TYPING; HUMAN; ILEUS; INFECTION; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MUCOSA INFLAMMATION; MYCOSIS; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PHILADELPHIA CHROMOSOME POSITIVE CELL; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; SCHOOL CHILD; SEIZURE; SEPSIS; SIDE EFFECT; SPAIN; THROMBOCYTOPENIA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PHILADELPHIA CHROMOSOME; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PYRIMIDINES; SPAIN; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 80051578925     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08783.x     Document Type: Article

References (45)

1. Aricó, M., Valsecchi, M.G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., Pui, C.H. & Masera, G. (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. New England Journal of Medicine, 342, 998-1006.
2. Aricó, M., Schrappe, M., Hunger, S.P., Carroll, W.L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L.B., Pui, C.H. & Valsecchi, M.G. (2010) Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia treated between 1995 and 2005. Journal of Clinical Oncology, 28, 4755-4761.
3. Badell, I., Muñoz, A., Estella, J., Fernandez-Delgado, R., Javier, G., Verdeguer, A. & Cubells, J. (2008) Long-term results of two consecutive trials in childhood acute lymphoblastic leukaemia performed by the Spanish Cooperative Group for Childhood Acute Lymphoblastic Leukemia Group (SHOP) from 1989 to 1998. Clinical and Translational Oncology, 10, 117-124.
4. Baron, F. & Storb, R. (2004) Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review. Seminars in Immunopathology, 26, 71-94.
5. Barr, R.D. (2010) Imatinib mesylate in children and adolescents with cancer. Pediatric Blood and Cancer, 55, 18-25.
6. Bassan, R., Rossi, G., Pogliani, E.M., Di, B.E., Angelucci, E., Cavattoni, I., Lambertenghi-Deliliers, G., Mannelli, F., Levis, A., Ciceri, F., Mattei, D., Borlenghi, E., Terruzzi, E., Borghero, C., Romani, C., Spinelli, O., Tosi, M., Oldani, E., Intermesoli, T. & Rambaldi, A. (2010) Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00. Journal of Clinical Oncology, 28, 3644-3652.
7. Bhojwani, D., Howard, S.C. & Pui, C.H. (2009) High-risk childhood acute lymphoblastic leukemia. Clinical Lymphoma and Myeloma, 9(Suppl. 3), S222-S230.
8. Biondi, A. (2006). 38th Congress of the International Society of Paediatric Oncology. Geneva, Switzerland September 17-21, 2006-SIOP Education Book 2006, pp 55-58.
9. Burke, M.J., Cao, Q., Trotz, B., Weigel, B., Kumar, A., Smith, A. & Verneris, M.R. (2009) Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Pediatric Blood and Cancer, 53, 1289-1294.
10. Castillo, E., Al-Rajabi, R., Pandya, D.M., Varadarajan, P., Kelly, K.R., Swords, R., Tharian, A., Kraus, M.K. & Padmanabhan, S. (2010) A pilot study of the combination of nilotinib and Hyper-CVAD for Philadelphia chromosome positive acute lymphocytic leukemia and lymphoid blast crisis chronic myelogenous leukemia. Blood (ASH Annual Meeting Abstracts), 116, 2144.
11. Cazzaniga, G., Lanciotti, M., Rossi, V., Di, M.D., Arico, M., Valsecchi, M.G., Basso, G., Masera, G., Micalizzi, C. & Biondi, A. (2002) Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response. British Journal of Haematology, 119, 445-453.
12. Champagne, M.A., Capdeville, R., Krailo, M., Qu, W., Peng, B., Rosamilia, M., Therrien, M., Zoellner, U., Blaney, S.M. & Bernstein, M. (2004) Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study. Blood, 104, 2655-2660.
13. van Dongen, J.J., Macintyre, E.A., Gabert, J.A., Delabesse, E., Rossi, V., Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., Parreira, A., Gameiro, P., Diaz, M.G., Malec, M., Langerak, A.W., San Miguel, J.F. & Biondi, A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia, 13, 1901-1928.
14. Esperou, H., Boiron, J.M., Cayuela, J.M., Blanchet, O., Kuentz, M., Jouet, J.P., Milpied, N., Cahn, J.Y., Faucher, C., Bourhis, J.H., Michallet, M., Tanguy, M.L., Vernant, J.P., Gabert, J., Bordigoni, P., Ifrah, N., Baruchel, A. & Dombret, H. (2003) A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society. Bone Marrow Transplantation, 31, 909-918.
15. Fielding, A.K., Buck, G., Lazarus, H.M., Litzow, M.R., Luger, S., Marks, D.I., Luger, S., Marks, D.I., McMillan, A., Moorman, A.V., Paietta, E., Richards, S.M., Tallman, M.S., Rowe, J.M. & Goldstone, A.H. (2010) Imatinib significantly enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukaemia; final results of the UKALLXII/ECOG2993 trial. Blood, 116, 169.
16. Fine, J.P. & Gray, R.J. (1999) A proportional hazards model for subdistribution of a competing risk. Journal of the American Statistical Association, 94, 496-509.
17. Gabert, J., Beillard, E., van der Velden, V.H., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J.M., Cave, H., Pane, F., Aerts, J.L., De, M.D., Thirion, X., Pradel, V., Gonzalez, M., Viehmann, S., Malec, M., Saglio, G. & van Dongen, J.J. (2003) Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program. Leukemia, 17, 2318-2357.
18. Gandemer, V., Auclerc, M.F., Perel, Y., Vannier, J.P., Le, G.E., Demeocq, F., Schmitt, C., Piguet, C., Stephan, J.L., Lejars, O., Debre, M., Jonveaux, P., Cayuela, J.M., Chevret, S., Leverger, G. & Baruchel, A. (2009) Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study. BMC Cancer, 9, 14.
19. Gooley, T.A., Leisenring, W., Crowley, J. & Storer, B.E. (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine, 18, 695-706.
20. Heerema, N.A., Harbott, J., Galimberti, S., Camitta, B.M., Gaynon, P.S., Janka-Schaub, G., Kamps, W., Basso, G., Pui, C.H., Schrappe, M., Auclerc, M.F., Carroll, A.J., Conter, V., Harrison, C.J., Pullen, J., Raimondi, S.C., Richards, S., Riehm, H., Sather, H.N., Shuster, J.J., Silverman, L.B., Valsecchi, M.G. & Arico, M. (2004) Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia, 18, 693-702.
21. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
22. Lee, S., Kim, Y.J., Min, C.K., Kim, H.J., Eom, K.S., Kim, D.W., Lee, J.W., Min, W.S. & Kim, C.C. (2005) The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood, 105, 3449-3457.
23. Lee, S., Kim, Y.J., Chung, N.G., Lim, J., Lee, D.G., Kim, H.J., Min, C.K., Lee, J.W., Min, W.S. & Kim, C.C. (2009) The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Cancer, 115, 561-570.
24. Martino, R., Santamaria, A., Pericas, R., Sureda, A. & Brunet, S. (1997) Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases. Haematologica, 82, 692-694.
25. Miller, A.B., Hoogstraten, B., Staquet, M. & Winkler, A. (1981) Reporting results of cancer treatment. Cancer, 47, 207-214.
26. Mitelman, F (ed.) (1995) ISCN 1995: An International System for Human Cytogenetic Nomenclature. S Karger, Basel, Switzerland.
27. Ottmann, O.G. & Pfeifer, H. (2009) First-line treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia in adults. Current Opinion in Oncology, 21(Suppl. 1), S43-S46.
28. Pane, F., Cimino, G., Izzo, B., Camera, A., Vitale, A., Quintarelli, C., Picardi, M., Specchia, G., Mancini, M., Cuneo, A., Mecucci, C., Martinelli, G., Saglio, G., Rotoli, B., Mandelli, F., Salvatore, F. & Foa, R. (2005) Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. Leukemia, 19, 628-635.
29. Peto, R. & Pike, M.C. (1973) Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics, 29, 579-584.
30. Pfeifer, H., Goekbuget, N., Völp, C., Hüttmann, A., Lübbert, M., Stuhlmann, R., Dengler, J., Kreuzer, K.A., Beck, J., Stelljes, M., Schmid, M., Wassmann, B., Leimer, L., Spiekermann, K., Terwey, T.H., Schäfer-Eckart, K., Ditz, D., Lindemann, H., Morgner, A., Schaich, M., Burmeister, T., Binckebanck, A., Hoelzer, D. & Ottmann, O.G. (2010) Long-term outcome of 335 adult patients receiving different schedules of imatinib and chemotherapy as front-line treatment for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood, 116, 173.
31. Pui, C.H. & Evans, W.E. (2006) Treatment of acute lymphoblastic leukemia. New England Journal of Medicine, 354, 166-178.
32. Rambaldi, A., Spinelli, O., Oldani, E., Grassi, A., Rossi, G., Pogliani, E.M., Di Bona, E., Angelucci, E., Cavattoni, I., Lambertenghi-Deliliers, G., Mannelli, F., Levis, A., Ciceri, F., Mattei, D., Borlenghi, E., Terruzzi, E., Borghero, C., Romani, C., Tosi, M., Bussini, A., Intermesoli, T. & Bassan, R. (2010) Improved clinical outcome of adult patients with Ph+ ALL after a combined imatinib-chemotherapy induction/consolidation program followed by allogeneic hematopoietic stem cell transplantation: results from a prospective study of the Northern Italy Leukemia Group. Blood, 116, 682.
33. Ravandi, F., O'Brien, S., Thomas, D., Faderl, S., Jones, D., Garris, R., Dara, S., Jorgensen, J., Kebriaei, P., Champlin, R., Borthakur, G., Burger, J., Ferrajoli, A., Garcia-Manero, G., Wierda, W., Cortes, J. & Kantarjian, H. (2010a) First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia. Blood, 116, 2070-2077.
34. Ravandi, F., Thomas, D.A., O'Brien, S., Faderl, S., Jorgensen, J., Luthra, R., Jones, D., Garris, R., Cortés, J.E. & Kantarjian, H. (2010b) Dynamics of minimal residual leukemia after combinations of the HyperCVAD regimen with imatinib or dasatinib in patients with Philadelphia-chromosome positive acute lymphoblastic leukemia. Blood, 116, 2127.
35. Ribeiro, R.C., Broniscer, A., Rivera, G.K., Hancock, M.L., Raimondi, S.C., Sandlund, J.T., Crist, W., Evans, W.E. & Pui, C.H. (1997) Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia, 11, 1493-1496.
36. Ribera, J.M., Oriol, A., Gonzalez, M., Vidriales, B., Brunet, S., Esteve, J., Del, P.E., Rivas, C., Moreno, M.J., Tormo, M., Martin-Reina, V., Sarra, J., Parody, R., de Oteyza, J.P., Bureo, E. & Bernal, M.T. (2010) Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial. Haematologica, 95, 87-95.
37. Roy, A., Bradburn, M., Moorman, A.V., Burrett, J., Love, S., Kinsey, S.E., Mitchell, C., Vora, A., Eden, T., Lilleyman, J.S., Hann, I. & Saha, V. (2005) Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial. British Journal of Haematology, 129, 35-44.
38. Satwani, P., Sather, H., Ozkaynak, F., Heerema, N.A., Schultz, K.R., Sanders, J., Kersey, J., Davenport, V., Trigg, M. & Cairo, M.S. (2007) Allogeneic bone marrow transplantation in first remission for children with ultra-high-risk features of acute lymphoblastic leukemia: a children's oncology group study report. Biology of Blood and Marrow Transplantation, 13, 218-227.
39. Schrappe, M., Arico, M., Harbott, J., Biondi, A., Zimmermann, M., Conter, V., Reiter, A., Valsecchi, M.G., Gadner, H., Basso, G., Bartram, C.R., Lampert, F., Riehm, H. & Masera, G. (1998) Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood, 92, 2730-2741.
40. Schultz, K.R., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Devidas, M., Wang, C., Davies, S.M., Gaynon, P.S., Trigg, M., Rutledge, R., Burden, L., Jorstad, D., Carroll, A., Heerema, N.A., Winick, N., Borowitz, M.J., Hunger, S.P., Carroll, W.L. & Camitta, B. (2009) Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. Journal of Clinical Oncology, 27, 5175-5181.
41. Thomas, D.A., Faderl, S., Cortes, J., O'Brien, S., Giles, F.J., Kornblau, S.M., Garcia-Manero, G., Keating, M.J., Andreeff, M., Jeha, S., Beran, M., Verstovsek, S., Pierce, S., Letvak, L., Salvado, A., Champlin, R., Talpaz, M. & Kantarjian, H. (2004) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood, 103, 4396-4407.
42. Towatari, M., Yanada, M., Usui, N., Takeuchi, J., Sugiura, I., Takeuchi, M., Yagasaki, F., Kawai, Y., Miyawaki, S., Ohtake, S., Jinnai, I., Matsuo, K., Naoe, T. & Ohno, R. (2004) Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia. Blood, 104, 3507-3512.
43. Tsai, M.S., Kuo, C.Y., Wang, M.C., Wu, H.C., Chien, C.C. & Liu, J.W. (2006) Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. Journal of Microbiology, Immunology, Infection, 39, 150-154.
44. Wassmann, B., Pfeifer, H., Goekbuget, N., Beelen, D.W., Beck, J., Stelljes, M., Bornhauser, M., Reichle, A., Perz, J., Haas, R., Ganser, A., Schmid, M., Kanz, L., Lenz, G., Kaufmann, M., Binckebanck, A., Bruck, P., Reutzel, R., Gschaidmeier, H., Schwartz, S., Hoelzer, D. & Ottmann, O.G. (2006) Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL). Blood, 108, 1469-1477.
45. Yanada, M., Sugiura, I., Takeuchi, J., Akiyama, H., Maruta, A., Ueda, Y., Usui, N., Yagasaki, F., Yujiri, T., Takeuchi, M., Nishii, K., Kimura, Y., Miyawaki, S., Narimatsu, H., Miyazaki, Y., Ohtake, S., Jinnai, I., Matsuo, K., Naoe, T. & Ohno, R. (2008) Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy. British Journal of Haematology, 143, 503-510.